Cadence Pharmaceuticals OFIRMEV (acetaminophen) injection, 1000 mg/100 mL (10 mg/mL) recall — FDA D-1432-2012
Presence of Particulate Matter: The firm initiated the recall due to visible presence of particulate matter.
Overview of recall records associated with Cadence Pharmaceuticals, including dates, categories and classifications where available.
Classification mix: Class II: 1.
Presence of Particulate Matter: The firm initiated the recall due to visible presence of particulate matter.
This page summarizes recall records in which the official source identifies Cadence Pharmaceuticals as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.